您的位置: 
            首页 
             >  
            农业专利 
             >  
            详情页 
        
        
            
                    COMPOSITION PHARMACEUTIQUE DE GLOBULES DE MATIERE GRASSE DU LAIT (MFG) DEPOURVUE DE ZINC 
                    
                    
                        专利权人: 
                        FARDOUSSI; KASSEM KHAL 
                     
                    
                        发明人: 
                        FARDOUSSI, KASSEM KHAL 
                     
                    
                        申请号: 
                        CA2879695 
                     
                    
                        公开号: 
                        CA2879695A1 
                     
                    
                        申请日: 
                        2012.07.27 
                     
                    
                        申请国别(地区): 
                        CA 
                     
                    
                        年份: 
                        2014 
                     
                    
                        代理人: 
                         
                     
                    
                    
                        摘要: 
                        A pharmaceutical composition comprising at least 20 wt% of milk fat globules (MGFs) and at least one C12-C20 fatty acid, and being free of zinc oxide for treating skin disorders and/or cell abnormal proliferation disorders. 
                     
                    
                        来源网站: 
                        中国工程科技知识中心 
                     
                    
                        来源网址: 
                        http://www.ckcest.cn/home/  
                     
                
             
            
                
                
                
                    相关专利 
                    
                        
                                ТВЕРДАЯ ФАРМАЦЕВТИЧЕСКАЯ ЛЕКАРСТВЕННАЯ ФОРМА 
                                 
                                chidamide crystal form a, method for preparing chidamide crystal form a, use of chidamide crystal form a, chidamide crystal form b, method for preparing chidamide crystal form b, use of chidamide crystal form b and pharmaceutical formulation for the treatment of diseases related to cell differentiation and proliferation 
                                 
                                PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING USES THEREOF 
                                 
                                PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF 
                                 
                                Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease